News

risperdal, boy,sad,breasts,sheller,lawsuit,lawyer,verdict

A Pennsylvania Superior Court has rejected Johnson & Johnson’s appeal of a 2016 $70 million verdict awarded to a 20 year-old Tennessee man, Andrew Yount (A.Y.) who developed gynecomastia after taking the antipsychotic
Risperdal green tablet

In a 6 to 1 decision, the Pennsylvania Supreme Court opened the door for thousands of pending Risperdal injury cases to proceed to trial. The seven-justice court ruled that a jury must decide,
Screen Shot 2019-11-29 at 11.17.47 AM

Stephen A. Sheller, founder of Sheller PC, is often sought for his expertise in litigation against pharmaceutical manufacturers whose products cause harm to consumers. He recently has one of few private law firms chosen to work
scales,of,justice,law,firm,lawyer,lawsuit,sheller,attorney,national,case,class,action,mass,tort

Several positive developments this month for young men injured from taking the Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The drug’s side effects included gynecomastia, the growth
pharma

Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and sales of opioid painkillers resulting in a nationwide
Sheller on Thom Hartman Show

From The Ring of Fire: Why Is Big Pharma Increasing Your Medicine Prices? By Thom Hartmann – July 17, 2019 The US pays more for medical drugs that in any country in the
Risperdal,FDA,petition,sheller,approval,appeal,woodcock,janet

In another win for plaintiffs injured by Risperdal, a Pennsylvania appellate court reversed a trial courts decision to grant the defendants motion for nonsuit, mid-trial. This decision will send the case back to
Various tablets

Purdue Pharma is named the main defendant in multiple city, state and local lawsuits against the pharmaceutical companies that played a part in the current opioid crisis. The suits claim the drug maker’s aggressive
Risperdal,FDA,petition,sheller,approval,appeal,woodcock,janet

Two cases in front of the Pennsylvania Supreme Court could result in 40% of the over 7,000 Risperdal cases being time barred from moving forward. The Pennsylvania docket for Risperdal cases has grown
Unknown-1

Attorney Stephen Sheller, founder of Sheller PC, will be honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement Ceremony on May 16. The Beasley School